src="https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sUSFEXdqY_hVtuFWo4pm1ejsmB1u9rRToe2D7af_YO70JdT7L8hHPHjF2bxEdNZLLQzJKNE7g5l5hCVxYcVwOCtirEkzrDCOi7bTWrdzraxF2d1BrdEA=s0-d"> Hereditary leiomyomatosis and renal cell cancer (HLRCC, also known as multiple cutaneous and uterine leiomyomatosis, MCUL) is a highly penetrant autosomal dominant tumor predisposition syndrome characterized by benign leiomyomas of the skin and the uterus
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant syndrome characterized by skin piloleiomyomas, uterine leiomyomas and papillary type 2 renal cancer caused by germline
E-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo
[Return to Medical Expert][Return to Cancer Expert]
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant syndrome characterized by skin piloleiomyomas, uterine leiomyomas and papillary type 2 renal cancer caused by germlineFor more information on each topic click the link(s) above.
You may also be interested in downloading ctMedBrowser for a unique viewing experience.
Contact
Web : http://c-t-search.infoE-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo
